Assignee
LYCIA THERAPEUTICS INC
US·1 granted patent·9 pending applications·0 citations·filing 2021–2024
Top patents by PatentIndex Score
10 records- 0171US12258332B2ASGPR cell surface receptor binding compounds and conjugatesLYCIA THERAPEUTICS INC·Filed 2023·Granted Mar 25, 2025·0 cites·18 claims
- 0271US2025101007A1Asgpr cell surface receptor binding compounds and conjugatesLYCIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0361US2026055194A1Bispecific antibodies and constructs for lysosomal targeting degradation and methods of use thereofLYCIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0455US2024335544A1M6pr cell surface receptor binding compounds and conjugatesLYCIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0553US2024165250A1Bifunctional Folate Receptor Binding CompoundsLYCIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0653US2025127913A1Bifunctional folate receptor binding compoundsLYCIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0750US2024279360A1Bifunctional compounds containing igf-2 polypeptidesLYCIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0848US2023158155A1Cell Surface Receptor Binding Compounds and ConjugatesLYCIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0947US2023279426A1Modified viral compositions for viral transductionLYCIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1043US2023226214A1Bifunctional bridging compositions for viral transductionLYCIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →